Oxidative stress and neopterin abnormalities in schizophrenia: A longitudinal study

Journal of Psychiatric Research

Volumn 44, Issue 5, 2010, Pages 310-313

  Chittiprol, Seetharamaiah ^a,b   Venkatasubramanian, Ganesan ^a   Neelakantachar, Narendran ^a   Babu, S V Suresh ^a   Reddy, Naveen A ^a   Shetty, K Taranath ^a   Gangadhar, Bangalore N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Anti oxidants; Neopterin; Nitrites; Oxidative stress; Schizophrenia; Thiols

Indexed keywords

ANTIOXIDANT; FLUPENTIXOL; NEOPTERIN; NEUROLEPTIC AGENT; NITRITE; OLANZAPINE; RISPERIDONE; THIOL; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; NEUROCHEMISTRY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPTERIN; OXIDATIVE STRESS; SCHIZOPHRENIA;

EID: 77649191025     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2009.09.002     Document Type: Article

References (32)

1. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS) (1983), University of Iowa, Iowa City, IA
2. Andreasen N.C. The Scale for the Assessment of Positive Symptoms (SAPS) (1984), University of Iowa, Iowa City, IA
3. Benzie F.F., and Strain J.J. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods in Enzymology (1999) 299
4. Dakhale G., Khanzode S., Saoji A., Khobragade L., and Turankar A. Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49 (2004) 205-209
5. Dietrich-Muszalska A., Olas B., Glowacki R., and Bald E. Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology 59 (2009) 1-7
6. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 163 (2006) 521-528
7. Elman G.L. Tissue sulfhydral groups. Archives of Biochemistry and Biophysics 82 (1959) 70-77
8. Evans D.R., Parikh V.V., Khan M.M., Coussons C., Buckley P.F., and Mahadik S.P. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, Leukotrienes, and Essential Fatty Acids 69 (2003) 393-399
9. Faul F., Erdfelder E., Lang A.G., and Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 39 (2007) 175-191
10. Guy W. Abnormal Involuntary Movements Scale (AIMS). In: ECDEU Assessment Manual for Pharmacology. Rockville, MD: US Dept of Health, Education, and Welfare; 1976 .
11. Korte S., Arolt V., Peters M., Weitzsch C., Rothermundt M., and Kirchner H. Increased serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophrenia Research 32 (1998) 63-67
12. Mahadik S.P., Evans D., and Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 25 (2001) 463-493
13. Mahadik S.P., Mukherjee S., Scheffer R., Correnti E.E., and Mahadik J.S. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biological Psychiatry 43 (1998) 674-679
14. McCreadie R.G., MacDonald E., Wiles D., Campbell G., and Paterson J.R. The Nithsdale Schizophrenia Surveys. XIV: plasma lipid peroxide and serum vitamin E levels in patients with and without tardive dyskinesia, and in normal subjects. The British Journal of Psychiatry 167 (1995) 610-617
15. Murr C., Fuith L.C., Widner B., Wirleitner B., Baier-Bitterlich G., and Fuchs D. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress?. Anticancer Research 19 (1999) 1721-1728
16. Murr C., Widner B., Wirleitner B., and Fuchs D. Neopterin as a marker for immune system activation. Current Drug Metabolism 3 (2002) 175-187
17. Nikkila H.V., Ahokas A., Wahlbeck K., Rimon R., and Andersson L.C. Neopterin and macrophage inflammatory protein-1alpha in the cerebrospinal fluid of schizophrenic patients: no evidence of intrathecal inflammation. Neuropsychobiology 46 (2002) 169-172
18. Pillai A., Parikh V., Terry Jr. A.V., and Mahadik S.P. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research 41 (2007) 372-386
19. Pillai A., Terry Jr. A.V., and Mahadik S.P. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophrenia Research 82 (2006) 95-106
20. Ramirez J., Garnica R., Boll M.C., Montes S., and Rios C. Low concentration of nitrite and nitrate in the cerebrospinal fluid from schizophrenic patients: a pilot study. Schizophrenia Research 68 (2004) 357-361
21. Reddy R.D., and Yao J.K. Free radical pathology in schizophrenia: a review. Prostaglandins, Leukotrienes, and Essential Fatty Acids 55 (1996) 33-43
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 Suppl. 20 (1998) 22-33 quiz 34-57
23. Sirota P., Gavrieli R., and Wolach B. Overproduction of neutrophil radical oxygen species correlates with negative symptoms in schizophrenic patients: parallel studies on neutrophil chemotaxis, superoxide production and bactericidal activity. Psychiatry Research 121 (2003) 123-132
24. Sperner-Unterweger B., Barnas C., Fleischhacker W.W., Fuchs D., Meise U., Reibnegger G., et al. Is schizophrenia linked to alteration in cellular immunity?. Schizophrenia Research 2 (1989) 417-421
25. Srivastava N., Barthwal M.K., Dalal P.K., Agarwal A.K., Nag D., Srimal R.C., et al. Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients. Psychopharmacology (Berlin) 158 (2001) 140-145
26. Sugino H., Futamura T., Mitsumoto Y., Maeda K., and Marunaka Y. Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 33 (2009) 303-307
27. Timothy A., Doane J., and William R.H. Spectrophotometric determination of nitrate with a single reagent. Analytical Letters 36 12 (2003) 2713-2722
28. Yao J.K., Reddy R., McElhinny L.G., and van Kammen D.P. Effects of haloperidol on antioxidant defense system enzymes in schizophrenia. Journal of Psychiatric Research 32 (1998) 385-391
29. Yao J.K., Reddy R., McElhinny L.G., and van Kammen D.P. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophrenia Research 32 (1998) 1-8
30. Yao J.K., Reddy R., and van Kammen D.P. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Research 97 (2000) 137-151
31. Yolken R.H., and Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 8 (1995) 131-145
32. Zhang X.Y., Zhou D.F., Qi L.Y., Chen S., Cao L.Y., Chen da C., et al. Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics. Psychopharmacology (Berlin) 204 (2009) 177-184